SelectScience
Join Free
Accelerating Science
NewsClinical Diagnostics

MedMira to Submit Cutting-Edge Rapid HIV Test for WHO Prequalification

MedMira Inc.
18 Mar 2014
Sonia Nicholas
Managing Editor and Clinical Lead

Product news

Complete testing solution optimizes time and money spent on programs to save more lives

MedMira Inc. will submit a new application for its most advanced Reveal Rapid HIV Antibody Test (Reveal HIV) to the WHO Prequalification of Diagnostics Programme. The latest version of Reveal HIV, recently approved in the European Union, delivers faster and more convenient point-of-care testing in the field through its simplified test procedure and the direct use of whole blood specimens. These new features are also in the Reveal and Multiplo products currently being commercialized in preparation for FDA submission.

The MedMira management team made the decision to submit its most advanced Reveal HIV test to the WHO for prequalification based on the company’s commitment to offer state-of-the-art technology and testing solutions to every corner of the world. Prequalification of the latest Reveal HIV format will also enable MedMira’s global strategic partners to bring the best technology and products to all markets where care providers and patients can benefit from faster, more cost-effective testing solutions. As MedMira rolls out this advanced version of Reveal HIV around the globe, legacy products will be phased out and the company will no longer support previous versions of the test, including the format originally submitted to the WHO for prequalification.

“Healthcare providers around the world are demanding the most advanced technology that qualified rapid test developers have to offer in order to meet the increasing need for screening tools that help prevent and control the spread of deadly diseases like HIV. By submitting Reveal HIV, built on the latest advances in our Rapid Vertical Flow Technology, for prequalification, MedMira is answering the WHO’s call for state-of-the art, innovative products needed in their programs,” said Hermes Chan, CEO, MedMira Inc.

Chan added, “Cost efficiency combined with high quality tests are critical to all government and non-government organizations running testing programs. MedMira is creating new modelling tools to help care providers optimize their program outputs and maximize available budgets, especially important in regions where large scale screening programs have the most impact. Our goal is to provide a comprehensive testing solution that includes the most advanced diagnostic technology, the highest quality tests, and optimization tools to save lives.”

Links

MedMira Inc.Company website

Tags

ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.HIV and AIDSBlood tests are the most common way to identify and monitor HIV and AIDS. Current methods include ELISA, Western blot, RT-PCR viral load and CD4/8 testing. Areas for development include point-of-care assays for use in developing countries, and self-testing ‘at home’ HIV kits.Point of Care SolutionsPoint of care solutions provide medical diagnostics and treatments at or near the site of patient care. These technologies offer rapid results, helping healthcare providers make quick decisions. From glucose monitors to molecular diagnostics, point of care solutions are transforming healthcare delivery by reducing wait times and improving patient outcomes. Explore the best point of care products in our peer-reviewed product directory, compare options, check reviews, and get pricing directly from manufacturers.

Related articles

MedMira to Submit Cutting-Edge Rapid HIV Test for WHO Prequalification